Singapore legislation

Regulation 2

of Interpretation (Health Sciences Authority Act — Fees) Order 2017

Regulation 2

Definitions

Amended byS 488/2024 wef 31/12/2021S 102/2021 wef 01/03/2021S 488/2024 wef 31/12/2021S 488/2024 wef 31/12/2021

In this Order —“Authority” means the Health Sciences Authority established under section 3 of the Health Sciences Authority Act 2001;“cell, tissue or gene therapy product” means a health product categorised as a cell, tissue or gene therapy product in the First Schedule to the Health Products Act 2007;“medical device” means a health product categorised as a medical device in the First Schedule to the Health Products Act 2007.

Definition

“Authority” means the Health Sciences Authority established under section 3 of the Health Sciences Authority Act 2001;

Amended byS 488/2024 wef 31/12/2021

Definition

“cell, tissue or gene therapy product” means a health product categorised as a cell, tissue or gene therapy product in the First Schedule to the Health Products Act 2007;

Amended byS 102/2021 wef 01/03/2021S 488/2024 wef 31/12/2021

Definition

“medical device” means a health product categorised as a medical device in the First Schedule to the Health Products Act 2007.

Amended byS 488/2024 wef 31/12/2021